🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
MARX Biotech Co., Ltd. (TPEX:7731)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
3.640
-0.310 (-7.85%)
Nov 20, 2026, 1:49 PM CST

MARX Biotech Revenue

MARX Biotech had revenue of 257.81M TWD in the half year ending June 30, 2026, with 20.32% growth. This brings the company's total for the last twelve months to 584.74M, down -17.97% year-over-year. In the year 2025, MARX Biotech had annual revenue of 635.85M with 2.85% growth. That makes MARX Biotech the 34,598th largest company in the world by revenue and 1,802nd in Taiwan.

Revenue (ttm)
584.74M
Revenue Growth
-17.97%
P/S Ratio
3.25
Revenue / Employee
n/a
Employees
80
Market Cap
1.90B

Revenue Chart

Revenue by Geography

  • Taiwan 632.33M 99.4%
  • United State 1.75M 0.3%
  • China 967.00K 0.2%
  • Singapore and Malaysia 800.00K 0.1%
Fiscal year ended Dec 31, 2025 See the full MARX Biotech breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025635.85M17.63M2.85%
Dec 31, 2024618.23M328.30M113.24%
Dec 31, 2023289.93M179.28M162.04%
Dec 31, 2022110.64M--
Dec 31, 2021---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.